|
KMID : 1044520230860030158
|
|
Tuberculosis and Respiratory Diseases
2023 Volume.86 No. 3 p.158 ~ p.165
|
|
|
Summary of Korean Asthma Guideline
|
|
Rhee Chin-Kook
Moon Ji-Yong
Joo Hyon-Soo
Jung Ji-Ye
Lee Jung-Kyu
Min Kyung-Hoon
Koo Hyeon-Kyoung
Lim Seong-Yong
Yoon Hyoung-Kyu
Lee Sang-Yeub
|
|
|
Abstract
|
|
|
Asthma is a chronic inflammatory airway disease that is characterized by variable airflowobstruction. The Korean Asthma Study Group of the Korean Academy of Tuberculosisand Respiratory Diseases has recently updated the Korean Asthma Guideline.
This review summarizes the updated Korean Asthma Guideline. Asthma prevalence isincreasing worldwide, and in Korea. Variable airflow obstruction can be confirmed bybronchodilator response or other tests, and should be established prior to the controllermedication. A low-dose inhaled corticosteroid-formoterol is used to alleviate symptomsin all treatment step, and it can be used as a controller as well as reliever in steps3?5. This approach is preferred, because it reduces the risk of severe exacerbations,compared to the use of short-acting β2-agonist as reliever. In severe asthma, phenotype/endotype based on the underlying inflammation should be evaluated. For type 2severe asthma, the biologics should be considered.
|
|
|
KEYWORD
|
|
|
Asthma, Guideline, Korea
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|